RE:RE:Big Competition is ON Agreed. The liquid biopsy space is huge. Stage will be the first to market. Even if it wasn't we would be a prime candidate for a buyout of a large pharma or healthcare company wanting to get in.
It's a win win that just needs Aristotle rolled out
can't wait for the conference call and update. Did I hear it was Tuesday pre market?
ScienceFirst wrote: I feel sad for OldAnus007. He's all mixed up. Unable to assess what Grail still has to do. Simply pathetic.
Funny, competition is not even an issue to me as all big players that don't have a liquid biopsy platform will want to jump in that lucrative 73B$ market. And that will only favor those that have one, like us. SLSZ is already building its network (large healtcare group, groups of clinics, etc ...). That will continue to grow until the launch, which will then bring us growing number of revenues.